According to VectivBio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 38.7067. At the end of 2022 the company had a P/S ratio of 19.9.
Year | P/S ratio | Change |
---|---|---|
2022 | 19.9 | |
2021 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Organovo ONVO | 44.7 | 15.58% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 17.4 | -55.03% | ๐ฌ๐ง UK |
Novavax NVAX | 0.9536 | -97.54% | ๐บ๐ธ USA |
Novocure
NVCR | 3.00 | -92.25% | Jersey |